Back to all assets

Corteva CTVA

equity

Price History

$23.5$43.9$64.29$84.69
2019-05 · DCA start$26.97

Time underwater

How far below its previous all-time high the price sat, each month. 0% means a new high.

-32.7%-21.8%-10.9%0.0%
2019-052026-08 · -10.8%

Worst drawdown: −33%, peaking Nov 2022 and bottoming Nov 2023 — 30 months below the prior high before recovering.

DCA Backtest

Invested
$8,800
Value today
$14,291
Return
+62.4%
Months invested
88

Scenarios

Inflation — the same contributions merely keeping pace with CPI would be $10,048 today, so the real (inflation-adjusted) return is +42.2%.

Lump sum instead — $8,800 all at once in May 2019: $24,645 (+180.1%) — lump sum came out ahead.

Worst timing — same monthly amount started at the all-time high (Jun 2026): $285.14 on $300 invested (-5.0%).

⚠ Price returns only — dividends are not included. This understates the true return of dividend-paying shares, and any comparison against crypto (which pays no dividends) is biased against equities by roughly the dividend yield, compounded.

If this saved you a spreadsheet — buy me a coffee.

Every start month at once

Each cell is the return-to-date of £/$/€100-a-month DCA started that month. Click a cell to load it in the backtest above. The ringed cell is the all-time-high start — the worst timing scenario.

JFMAMJJASOND
2019
2020
2021
2022
2023
2024
2025
2026
Legend:−50%−20%0%+50%+200%+1000%worst timing (ATH)Selected 2019-05: +62.4%

About Corteva

Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Its primary brand is Pioneer Hi-Bred International. (Wikipedia)

It's a listed company categorised under materials and fertilizers & agricultural chemicals, with a market cap of about $50.4B.

It rates Low Risk at 1.4/5, meaning the rated factors look benign — steady pricing, deep liquidity, and no obvious structural red flags.

Scoring well: earnings quality at 1.0/5.

Not yet researched: concentration, governance. These are excluded from the score rather than guessed, so the real risk may be higher than what’s shown.

Ratings summarise sourced facts against fixed rules — not investment advice, and no substitute for your own diligence.

Risk Profile

Low Risk(1.4/5)80% rated

How these ratings work

Market / Volatility2.0/5 · weight 20%
  • Annualised volatility (3yr)2/523.6
  • Max drawdown from ATH2/532.7
  • Beta vs S&P 5002/50.66
Liquidity1.0/5 · weight 15%
  • Avg daily $ volume1/5328.8m
  • Float % of shares outstandingnot yet researched
Leverage / Financial1.0/5 · weight 20%
  • Debt / equity1/50.07
  • Interest coverage (EBIT / interest)not yet researched
Earnings Quality1.0/5 · weight 15%
  • 3yr EPS volatility1/52.2
Concentrationunrated · weight 10%
  • Largest customer, % of revenuenot yet researched
  • Geographic revenue concentrationnot yet researched
Governanceunrated · weight 10%
  • Board independence %not yet researched
  • Share structurenot yet researched
  • Litigation / audit historynot yet researched
Sector / Regulatory2.0/5 · weight 10%
  • Sector regulatory exposure2/5moderate

Linked Assets

Same sector, or return-correlated — worth knowing what else might move if this one does.